β Life-Stage Preventive Screening · Apgujeong Hana Clinic
Women’s Health Screening Seoul
English-friendly women’s health screening in Gangnam—covering cardiovascular and metabolic risk, breast and cervical screening, colorectal and other risk-based cancer checks, bone health, reproductive planning, menopause, sexual health and mental well-being.
β
Life-stage risk review
β
Women-specific screening
β
English results consultation
Women’s Screening Compass
Preventive priorities change across life stages
Age + risk tailored
β
Women’s
Health Plan
Health Plan
BREAST & CERVIX
Mammography, HPV and cervical cytology according to eligibility.
HEART & METABOLIC
Blood pressure, glucose, lipids, weight and pregnancy-related risk.
REPRODUCTIVE & MENOPAUSE
Periods, fertility, contraception, pregnancy planning and symptoms.
BONE & HEALTHY AGING
Fracture risk, osteoporosis, falls and age-appropriate prevention.
Women’s screening should not be reduced to a pelvic ultrasound or hormone panel. The plan should use established screening, evaluate symptoms separately and adapt to reproductive history, menopause and long-term risk.
π
Breast & Cervical
Established screening methods selected by age and history.
β€οΈ
Cardiometabolic Health
Blood pressure, diabetes, lipids and weight-related risk.
πΈ
Reproductive & Menopause
Symptoms and planning are reviewed confidentially.
π¦΄
Bone & Healthy Aging
Osteoporosis, fracture, function and prevention priorities.
β
English Women’s Screening
β
Internal-Medicine Evaluation
β
Life-Stage Prevention
β
Apgujeong · Gangnam
What Is Women’s Health Screening?
A preventive review that changes with age, reproductive history and personal risk.
Women’s health screening combines general preventive care with breast, cervical, reproductive, pregnancy-related, menopause and bone-health considerations. The goal is to identify important risks before complications develop and to keep established screening up to date.
The visit may include blood pressure, glucose, lipids, liver and kidney assessment, selected blood or urine tests and appropriate cancer screening. It also creates a confidential opportunity to discuss menstrual changes, fertility, contraception, sexual health, pregnancy planning, menopause symptoms, mood and sleep.
Screening is intended for people without concerning symptoms. A new breast lump, postmenopausal bleeding, severe pelvic pain or unexplained weight loss requires diagnostic evaluation rather than waiting for routine screening.
π
Women-Specific Cancer Prevention
Breast and cervical screening have established methods and follow-up pathways.
β€οΈ
Chronic-Disease Prevention
Cardiovascular and metabolic risks may change after pregnancy and menopause.
πΈ
Reproductive Life Stages
Periods, contraception, fertility, pregnancy and menopause influence health needs.
π¦΄
Bone & Functional Health
Menopause and age can increase fracture risk and change prevention priorities.
Women’s Health Across Life Stages
Each stage brings different preventive priorities.
Early Adulthood
Build A Prevention Baseline
Blood pressure, vaccines, cervical screening eligibility, sexual health, mood, nutrition and family-history review.
Symptoms and personal risk determine whether additional testing is needed.
Reproductive Years
Integrate Pregnancy & Fertility Goals
Contraception, preconception care, folic acid, chronic disease, medicines, fertility concerns and pregnancy history.
Previous gestational diabetes or hypertension can affect future cardiometabolic risk.
Perimenopause
Review Changing Symptoms
Bleeding patterns, sleep, hot flushes, mood, weight, sexual health, blood pressure and bone risk.
Unexpected or heavy bleeding requires diagnostic assessment rather than routine screening.
Postmenopause & Aging
Protect Bone, Heart & Function
Mammography, colorectal screening, osteoporosis, falls, medicines, vaccination and chronic-disease prevention.
Screening continues only when expected benefit remains meaningful.
Life-stage categories guide discussion; they do not replace individual assessment
Family history, hereditary risk, previous abnormal results, chronic illness, pregnancy complications and treatment history may move screening earlier or create a surveillance pathway.
Core Health Risks
General preventive care remains central to women’s long-term health.
π©Ί
High Blood Pressure
Hypertension may be silent and contributes to heart, brain, kidney and pregnancy-related risk.
π¬
Diabetes & Prediabetes
Weight, family history and previous gestational diabetes may influence screening.
π§ͺ
Cholesterol & Vascular Risk
Lipids are interpreted with age, blood pressure, smoking, diabetes and menopause.
π«
Liver Health
Metabolic risk, alcohol, hepatitis and medicines may require focused review.
π«
Kidney Health
Blood pressure, diabetes, pregnancy complications and selected urine findings can affect risk.
π©Έ
Anaemia & Nutrient Risk
Heavy periods, pregnancy, restrictive diets or GI disease may justify targeted testing.
π
Sleep & Fatigue
Insomnia, sleep apnoea, thyroid symptoms, anaemia and mood may contribute.
π§
Mental Health
Depression, anxiety, trauma, alcohol and reproductive-life transitions deserve confidential assessment.
Breast & Cervical Screening
Use established screening methods and complete follow-up after an abnormal result.
π
Breast Cancer Screening
Current USPSTF guidance recommends mammography every two years from ages 40 to 74 for average-risk women. Risk, prior findings and national guidance may change the plan.
Mammography
πΈ
Cervical Cancer Screening
Cervical cytology, high-risk HPV testing or cotesting are used according to age and program. Korea’s national program lists Pap testing for eligible women aged 20 and over every two years.
HPV / Pap / Cotesting
π§¬
Hereditary Breast & Ovarian Risk
Early breast or ovarian cancer, multiple related cancers or a known familial mutation may justify genetics counselling and a specialist pathway.
Risk Review / Genetics
π
Dense Breasts & Prior Findings
Dense tissue, prior biopsy or an abnormal mammogram may change imaging follow-up. Additional imaging is not automatically required for every patient.
Personalised Imaging
π¦
HPV Prevention
HPV vaccination and cervical screening are complementary. Vaccination does not remove the need for screening when eligible.
Vaccination + Screening
π¬
Abnormal Result Follow-Up
Diagnostic mammography, ultrasound, colposcopy, biopsy or specialist review may be required before a diagnosis is confirmed.
Diagnostic Pathway
Other Cancer Screening
Women also need organ-specific screening outside breast and cervical care.
π§»
Colorectal Cancer
Options include stool testing and colonoscopy. International age thresholds vary; Korea’s national program lists annual FOBT from age 50.
FIT / FOBT / Colonoscopy
π½οΈ
Stomach Cancer
Korea’s national program lists screening from age 40 every two years using upper-GI imaging or gastroscopy, with biopsy when indicated.
Gastroscopy / UGI
π«
Liver Cancer
Surveillance is intended for defined high-risk adults with chronic hepatitis, cirrhosis or another qualifying risk—not all women.
Ultrasound + AFP
π«
Lung Cancer
Low-dose CT is for selected current or former smokers with sufficient exposure. It is not a routine test for every woman.
Low-Dose CT
π§¬
Hereditary Colorectal Risk
Lynch syndrome or early family colorectal and endometrial cancers may require specialist surveillance and genetic counselling.
Family History / Genetics
π
Previous Lesions
Polyps, dysplasia, nodules or prior cancer require surveillance rather than an average-risk screening schedule.
Surveillance Plan
Ovarian & Endometrial Cancer
Routine screening is not recommended for average-risk women without symptoms.
β What Is Clinically Appropriate
β
Assess persistent bloating, pelvic pain, early fullness or urinary change diagnostically.
β
Evaluate postmenopausal bleeding and persistent abnormal uterine bleeding promptly.
β
Review strong breast, ovarian, colorectal or endometrial family history.
β
Refer for genetic counselling when a hereditary syndrome is possible.
β
Use ultrasound, CA-125 or endometrial sampling when clinically indicated—not as a generic package.
β οΈ What Should Not Be Marketed As Routine Screening
!
Annual CA-125 testing for asymptomatic average-risk women.
!
Annual transvaginal ultrasound to prevent ovarian-cancer deaths.
!
A Pap test as a screen for ovarian or endometrial cancer.
!
Pelvic ultrasound as proof that all gynaecologic cancers are excluded.
!
Reassurance that ignores persistent or postmenopausal bleeding.
Symptoms change the pathway from screening to diagnosis
NCI notes that no standard routine endometrial-cancer screening test has been shown effective, and ovarian screening with CA-125 or transvaginal ultrasound has not reduced mortality in average-risk asymptomatic women.
Reproductive & Preconception Health
Preventive care can prepare for pregnancy—or support a decision not to become pregnant.
π€°
Pregnancy Planning
Review chronic disease, medicines, vaccines, folic acid, nutrition and previous pregnancy outcomes.
π
Contraception Safety
Blood pressure, smoking, migraine, clotting and medical history may affect method selection.
π§¬
Genetic & Family Risk
Carrier or genetics discussion may be relevant for selected family or ancestry risks.
π¦
STI Screening
Testing depends on age, pregnancy, symptoms, partners, exposure and prevention needs.
π©Έ
Menstrual Health
Heavy, irregular or painful periods may require focused evaluation for anaemia or underlying disease.
π±
Fertility Concerns
Cycle history, age, partner factors and duration of trying guide diagnostic evaluation.
π§ͺ
Pregnancy-Related Risk
Gestational diabetes, hypertension or preeclampsia history can affect future health screening.
π€
Safety & Well-Being
Relationship safety, reproductive coercion and mental health can be discussed confidentially.
Menopause & Bone Health
Menopause changes symptoms and risk—but does not automatically require a hormone panel.
Vasomotor Symptoms
Hot flushes and night sweats are assessed with sleep, medicines and treatment preferences.
Sleep & Mood
Insomnia, anxiety, depression and life stress may overlap with menopause symptoms.
Cardiovascular Risk
Blood pressure, glucose, lipids, smoking and activity remain central after menopause.
Osteoporosis Screening
USPSTF recommends screening women 65+ and younger postmenopausal women at increased risk.
Postmenopausal Bleeding
Any bleeding after menopause requires diagnostic assessment.
Hormone Therapy Review
Benefits, risks, symptoms, clotting, cancer history and alternatives require individual discussion.
Bone-health screening is based on age and fracture risk
A DXA scan may be appropriate at age 65 or earlier after menopause when risk factors are present. Calcium, vitamin D, resistance exercise, falls and medicines should be reviewed in context.
Your Screening Journey
From life-stage review to a clear prevention plan.
1
Share Your History
Provide family risk, periods, pregnancy history, menopause, medicines and previous results.
2
Select Screening
Choose core tests and women-specific age- or risk-based add-ons.
3
Prepare Correctly
Follow fasting, cycle timing, medicine, imaging or sedation instructions.
4
Complete Assessment
Undergo the planned consultation, laboratory, imaging or sampling tests.
5
Review & Act
Confirm diagnostic follow-up, treatment and future screening intervals.
How To Prepare
Preparation depends on the exact tests included.
π
Bring earlier reports and clarify pregnancy possibility.
Previous mammograms, cervical results, ultrasound, pathology, endoscopy, bone-density and laboratory reports help avoid duplication and improve interpretation.
π½οΈ
Fasting
Confirm the exact time to stop food and whether water is allowed.
π
Medicines
Ask about diabetes treatment, blood thinners, hormones and supplements.
π©Έ
Bleeding & Cycle Timing
Cervical sampling or selected assessments may need timing discussion.
π€°
Pregnancy Possibility
Tell the clinic before X-ray, CT, medication or sedation.
π
Previous Imaging
Bring prior mammography and breast images where available.
π
Sedation Transport
Gastroscopy or colonoscopy with sedation may require an escort and no driving afterward.
Understanding Results
A screening result should lead to a defined next step.
β
Continue Prevention
Maintain healthy behaviours and repeat screening at an appropriate interval.
π‘
Modify Risk
Address blood pressure, glucose, lipids, weight, smoking, alcohol, sleep or bone risk.
π
Confirm A Finding
Diagnostic imaging, colposcopy, endoscopy, repeat testing or biopsy may be needed.
π
Enter Surveillance
Previous lesions, high-risk genetics or confirmed disease may require scheduled follow-up.
Borderline results need context—not instant diagnosis
Hormones, liver enzymes, glucose, thyroid tests and other measurements can vary with timing, illness, medicines and life stage. Repeat testing may be more useful than immediate treatment.
Benefits & Limitations
Screening can reduce preventable harm, but low-value testing can create new problems.
β Potential Benefits
β
Detect selected breast, cervical and chronic-disease risks earlier.
β
Identify overdue colorectal, stomach, lung or liver screening.
β
Support preconception, menopause and bone-health planning.
β
Create a baseline for meaningful future comparison.
β
Connect menstrual, sexual, reproductive and mental-health concerns to appropriate care.
β οΈ Important Limitations
!
False-positive results can lead to anxiety and invasive follow-up.
!
False-negative results can provide incorrect reassurance.
!
Routine CA-125, pelvic ultrasound or broad hormone panels may be low value.
!
Overdiagnosis may identify disease that would never have caused harm.
!
Screening does not replace diagnostic assessment of active symptoms.
Symptoms That Need Diagnostic Care
Do not wait for routine screening when warning symptoms are present.
π
New Breast Lump
A new lump, nipple change, skin dimpling or bloody discharge needs diagnostic assessment.
π©Έ
Postmenopausal Bleeding
Any bleeding after menopause requires prompt evaluation.
πΈ
Persistent Abnormal Bleeding
Heavy, irregular or bleeding after sex may require focused gynaecologic assessment.
β οΈ
Severe Pelvic Pain
Sudden severe pain, fainting, pregnancy possibility or heavy bleeding can be urgent.
π
Unexplained Weight Loss
Persistent unintended weight loss should not be managed as routine screening.
π©Έ
Blood in Stool or Urine
Visible bleeding, black stool or recurrent blood requires diagnostic evaluation.
π«
Persistent Cough or Breathlessness
Ongoing or worsening respiratory symptoms require assessment.
π§
Neurological Change
Facial droop, weakness, speech difficulty or acute confusion requires emergency care.
Apgujeong, Gangnam
Women’s health screening with English support.
Apgujeong Hana Clinic provides internal-medicine risk review, tailored preventive testing, women-specific screening guidance and clear results follow-up for expats, residents and international patients in Seoul.
π
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
π
Monday–Friday 09:00–19:00
ποΈ
Saturday 09:00–13:00
π
02) 3443-7550
π©Ί
Internal-Medicine Screening Review
Your life stage, medical history and screening results are combined into a practical plan for prevention, diagnostic follow-up and appropriate referral.
FAQ
Women’s health screening questions, answered.
Exact tests, start ages, intervals, preparation and coverage depend on personal risk, current guidance and the confirmed clinic package.
A women's screening visit may include medical history, blood pressure, weight and waist review, selected blood and urine tests, cardiometabolic assessment, breast and cervical screening guidance, colorectal and other risk-based cancer screening, bone-health review and discussion of menstrual, reproductive, menopause, sexual and mental health.
Guidelines vary by country and risk. The current USPSTF recommends mammography every two years from ages 40 to 74 for average-risk women. Strong family history, genetic risk or a prior breast lesion may require a different pathway.
The interval depends on age, test method and previous results. Common international options use cervical cytology, high-risk HPV testing or cotesting. Korea's national program lists a Pap smear every two years for eligible women aged 20 and over.
No. Routine ovarian cancer screening with CA-125 or transvaginal ultrasound is not recommended for asymptomatic average-risk women because it has not reduced mortality and can lead to false positives and unnecessary surgery.
There is no standard routine screening test for average-risk women without symptoms. Postmenopausal bleeding, persistent abnormal bleeding or other concerning symptoms require diagnostic assessment.
The USPSTF recommends osteoporosis screening for women aged 65 and older and for postmenopausal women younger than 65 who are assessed as being at increased fracture risk.
Yes. Pregnancy plans, contraception, folic acid, vaccination, medicine safety, chronic disease and genetic or fertility concerns can be discussed. This is personalised counselling rather than one universal test panel.
Menopause symptoms, bleeding, bone risk, sleep and cardiometabolic health can be reviewed. Hormone tests are not automatically needed for every woman and should be selected according to symptoms and clinical context.
Some combined laboratory or imaging programs require fasting, while others do not. Follow the clinic's exact instructions about food, water, alcohol, exercise and medicines.
Yes. Apgujeong Hana Clinic provides English booking support, preparation guidance, internal-medicine screening, results explanation and follow-up for international patients in Seoul.
Related Health Screening Programs
Choose the next screening pathway according to your priorities.
English Women’s Screening
Build a prevention plan for your current life stage—and the years ahead.
Contact Apgujeong Hana Clinic to discuss age, family history, reproductive history, menopause, previous results, symptoms and preparation requirements.